Mobile-health Network Solutions Signs MOU to Secure Two Malaysian AI Data Center Projects; Facilities Intended to Power Expansion of Company's AI Digital Health PlatformNovember 21, 2025 8:30 AM EST | Source: Mobile-health Network SolutionsSingapore, Singapore--(Newsfile Corp. - November 21, 2025) - Mobile-health Network Solutions (NASDAQ: MNDR) ("MNDR" or the "Company"), a leading AI HealthTech platform, today announced the signing of a legally binding Memorandum of Understanding (MOU) with P ...

Function Health raises $298M Series B at $2.5B valuation https://t.co/bL8DYdXic0 ...

DALLAS, Nov. 19, 2025 (GLOBE NEWSWIRE) -- Spectral AI, Inc. (Nasdaq: MDAI) (“Spectral AI” or the “Company”), an artificial intelligence (AI) company focused on medical diagnostics for faster and more accurate treatment decisions in wound care, today announced its prominent role at the Southern Region Burn Conference, held from October 30th – November 2nd in Charleston, South Carolina. The Company was featured in multiple presentations, highlighting its contributions to advancing burn care across the country ...

Company Overview - Prickly Pear Health 专注于女性脑部健康医疗支持 [1] - 公司提供基于 AI 驱动的语音助手，帮助 30-50 岁女性应对影响脑部健康的荷尔蒙变化 [1]

Core Insights - Spectral AI, Inc. has been recognized in TIME's World's Top HealthTech Companies 2025 list, highlighting its innovative contributions to medical diagnostics in wound care [1][2][3] Company Overview - Spectral AI is a Dallas-based predictive AI company focused on enhancing medical diagnostics for wound care, particularly for burn patients [3] - The company is developing the DeepView System, which aims to provide clinicians with an objective assessment of a burn wound's healing potential before treatment [3] - The DeepView System is designed to improve patient outcomes and reduce healthcare costs by offering fast and accurate treatment insights [3] Recognition and Impact - The TIME list, compiled with Statista Inc., evaluated thousands of HealthTech companies, recognizing 400 for their financial performance, reputation, and online engagement [2] - J. Michael DiMaio, M.D., Chairman of Spectral AI, emphasized that this recognition is a significant milestone for the company and its technology [3]

Core Insights - Juisci, a HealthTech startup, has raised €5.5 million in Seed funding to enhance R&D, expand its team, and accelerate international growth, particularly in the U.S. market [1] - The platform aims to provide healthcare professionals with quick and trustworthy access to scientific knowledge, helping them save time and combat misinformation [2][3] Company Overview - Founded in 2021 by Robin Roumengas and Dr. David Luu, Juisci is a SaaS platform that democratizes access to scientific knowledge through proprietary AI and a mobile-first experience [3] - The platform currently has over 200,000 users across 60 countries and supports 10 languages, collaborating with major pharmaceutical companies, MedTech firms, and hospitals [4][6] Market Need - The volume of medical knowledge is rapidly increasing, doubling every 73 days, making it challenging for healthcare professionals to keep up with the latest research [5] - Juisci addresses this issue by utilizing AI specifically trained on scientific literature to convert extensive research into clear and reliable insights [5] Product Features - The platform offers digestible summaries, article recommendations, videos, podcasts, and infographics, enabling healthcare professionals to save up to 8 hours a week [6] - Juisci has secured over 30 major clients, including well-known companies like Sanofi, UCB, and Johnson & Johnson, as well as various hospitals and scientific societies [7]

Core Insights - Butterfly Network Inc. (BFLY) shares surged 14.81% to $2.17 in after-hours trading after being named to TIME's inaugural list of the World's Top HealthTech Companies for 2025 [1] - The company had already experienced a 15.95% increase during regular trading, closing at $1.89 [1] Company Recognition - Butterfly Network was selected from thousands of HealthTech companies, evaluated based on financial performance, reputation analysis, and online engagement data [2] - The recognition underscores the company's innovation in hardware and software, aiming to enhance ultrasound accessibility [3] Product Performance - The iQ3 device from Butterfly Network won the Best Medical Technology award at the 2024 Prix Galien USA Awards, highlighting its market impact [3] Market Performance - Despite a 39.42% loss for 2025 so far, BFLY has gained 36.96% in the past month [4] - The stock price peaked at $4.82 on February 18, 2025, but closed at $1.89, reflecting a 60.7% decrease [4] - BFLY trades within a 52-week range of $1.66 to $13.56, with a market capitalization of $475.79 million and an average daily volume of 2.91 million shares [4]

Core Points - MEDIROM Healthcare Technologies Inc. has partnered with Hakuhodo Inc. to promote the adoption of World ID in Japan, a protocol designed to verify human authenticity in the AI era [3][4] - The collaboration aims to install the "Orb" verification device in approximately 100 Re.Ra.Ku relaxation salons, with a target of issuing 500,000 new World IDs annually by the end of December 2025 [5][12] Company Overview - MEDIROM operates over 300 relaxation salons under the "Re.Ra.Ku" brand and has expanded into HealthTech, offering various health-related services and products [19] - Hakuhodo will provide planning and operational support as a flagship partner in the domestic expansion of the World project [12] - Tools for Humanity (TFH) is responsible for providing the World technology, platform operation, and security supervision, ensuring user privacy and control [12][16] Technology and Implementation - World ID is a global personal authentication technology that aims to provide digital proof of human identity, especially in a landscape increasingly populated by generative AI [9] - The "Orb" device utilizes advanced camera technology to verify individuals' humanness without compromising their identity [9][10] - Once verified, users can store their World ID in the "World App," allowing access to various compatible services [10] Market Context - The initiative is part of a broader global effort to build tools that help humanity adapt to the AI era, increasing online trust by distinguishing between humans and AI [8] - The project is co-founded by notable figures in the tech industry, including Sam Altman, aiming to create a new economic system where only verified humans can access certain services [8]

Core Insights - Nebius has launched its inaugural AI Discovery Awards to support innovative companies in healthcare and life sciences, providing over $850,000 in GPU cloud and inferencing credits [1][6] Group 1: Award Winners and Their Innovations - Ataraxis AI won for its cancer treatment prediction platform, achieving 30% higher accuracy than standard genomic tests in clinical validation across 7,500 patients [2] - Aikium focuses on targeting "undruggable" proteins, which comprise half of the human proteome, using its Yotta-ML² platform and has secured partnerships with three top cancer hospitals [3] - Transcripta Bio has developed a high-resolution transcriptomic atlas with over a billion gene responses, recently partnering with Microsoft Research to identify new disease-gene associations [4] - MetaSight Diagnostics is pioneering advanced blood testing for population-scale disease diagnostics, creating the world's largest blood molecular database from over 500,000 participants [5] Group 2: Award Structure and Benefits - Each category winner receives $100,000 in GPU credits, with second and third places receiving $50,000 and $30,000 respectively, along with mentorship and networking support [7] - Seven "honorable mentions" in each category receive $5,000 in GPU cloud credits, and all participants are granted inferencing credits for Nebius AI Studio [7] Group 3: Industry Impact and Future Directions - Nebius aims to connect promising companies leveraging AI in healthcare with the necessary computational infrastructure and expertise to scale their innovations [6] - The awards highlight significant advancements in applying AI to healthcare challenges, such as predicting cancer treatment outcomes and targeting previously undruggable proteins [8]